BioSpace News Archive

Business

China’s Laekna Inks Two-Drug Deal with Novartis

Laekna, headquartered in Shanghai, China, signed a deal with Novartis Pharma AG for exclusive worldwide rights to two oral Novartis clinical-stage cancer drugs.

August 1, 2018
·
2 min read
·
Mark Terry
Drug Development

BioLineRx Initiates Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it has initiated a Phase 1/2a clinical study for AGI-134.

August 1, 2018
·
7 min read
Business

Oncorus®, Inc., Names Industry Veteran Ted Ashburn as new President and CEO

Company co-founder Mitch Finer named new Chairman of the Board

August 1, 2018
·
3 min read
Business

Alkahest, Inc. Announces Key Appointment of Bruce Morimoto, PhD

Bruce Morimoto joins Alkahest as Vice President, Drug Development Operations

August 1, 2018
·
2 min read
Business

Theravance Biopharma, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

TD-1473 Advancing into Phase 2b/3 Study in Ulcerative Colitis in Fourth Quarter Following Completion of Phase 1b Study and Successful Dialogues with FDA and EMA

August 1, 2018
·
22 min read
Deals

NED Biosystems Raises $2 Million in Series B Financing Round and Appoints New CEO

Company Announces New Members to Scientific Advisory Board

August 1, 2018
·
4 min read
Pharm Country

Newron Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

Newron Pharmaceuticals S.p.A. announced that Stefan Weber, CEO, will present at the Wedbush PacGrow Healthcare Conference in New York, NY, on Wednesday, August 15, 2018 at 1:20 p.m. ET.

August 1, 2018
·
1 min read
Biotech Beach

Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy

Immunotherapy Focused Consulting Company Provides Independent Support of the Value of Daily Body Restore® for Cancer Patients

August 1, 2018
·
3 min read
Business

The Medicines Company Reports Second-Quarter 2018 Results

The Medicines Company (NASDAQ:MDCO) today reported its financial results for the second quarter ended June 30, 2018.

August 1, 2018
·
16 min read
Business

The American Legion joins forces with AbbVie to launch TAKE ON HEP C, a national hepatitis C awareness and testing tour

The TAKE ON HEP C tour will travel to select events in 2018 and provide free hepatitis C testing and access to VA benefits counseling

August 1, 2018
·
4 min read